期刊
DRUG DISCOVERY TODAY
卷 25, 期 12, 页码 2130-2148出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.09.022
关键词
-
资金
- Fondazione Umberto Veronesi 'Postdoctoral Fellowships 2020'
Axl receptor tyrosine kinase (RTK) and its ligand, growth arrest-specific protein 6 (Gas6), are involved in several biological functions and participate in the development and progression of a range of malignancies and autoimmune disorders. In this review, we present this molecular system from a drug discovery perspective, highlighting its therapeutic implications and challenges that need to be addressed. We provide an update on Axl/Gas6 axis biology, exploring its role in fields ranging from angiogenesis, cancer development and metastasis, immune response and inflammation to viral infection. Finally, we summarize the molecules that have been developed to date to target the Axl/Gas6 molecular system for and
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据